Table 5 Difference in cost and effects; ICUR and ICER between intervention and control patients for the main and sensitivity analyses based on adjusted models
Cost difference (95% CI) in € | QALY difference (95% CI) | ICUR (€/QALY) | Difference in change in two or three behaviours in one patient (95% CI)d | ICER (€/extra change in two or three behaviours in one patient) | REGICOR reduction difference (95% CI) | ICER (€/REGICOR reduction) | |
|---|---|---|---|---|---|---|---|
Main analysis - Societal perspective (ITT and minimum wage) | 295.02 (− 1402.75; 1992.78) | − 0.009 (− 0.03; 0.01) | Dominated | 5.27 (2.59; 7.78) | 5598 | 0.04 (− 0.12; 0.21) | 6926 |
Main analysis – Healthcare system perspective (ITT and minimum wage) | 207.20 (− 1901.24; 2315.63) | − 0.009 (− 0.03; 0.01) | Dominated | 5.27 (2.59; 7.78) | 3932 | 0.04 (− 0.12; 0.21) | 4864 |
Mean wage (Societal perspective) | 433.19 (− 1487.19; 2354.10) | − 0.009 (− 0.03; 0.01) | Dominated | 5.27 (2.59; 7.78) | 8220 | 0.04 (− 0.12; 0.21) | 10,169 |
Maximum regional tariffsa | 266.19 (− 2405.15 2507.52) | − 0.009 (− 0.03; 0.01) | Dominated | 5.27 (2.59; 7.78) | 5051 | 0.04 (− 0.12; 0.21) | 6285 |
Minimum regional tariffs | 271,64 (− 1137.75; 1681.02) | −0.009 (− 0.03; 0.01) | Dominated | 5.27 (2.59; 7.78) | 6377 | 0.04 (− 0.12; 0.21) | 5154 |
Complete-case | 126.76 (−1.535.45; 1788.98) | −0.009 (− 0.024; 0.006) | Dominated | 5.68 (3.41;7.99) | 2224 | 0.06 (− 0.10; 0.21) | 2174 |
Unadjusted analysisb | 343.60 (− 1406.84; 2094.05) | −0.011 (− 0.032; 0.011) | Dominated | 4.47 (2.82; 8.09) | 7690 | 0.05 (− 0.12; 0.21) | 7288 |
SUR | 129.82 (− 16.79; 276.43)c | −0.008 (− 0.016; − 0.001) | Dominated | NA | NA | 0.04 (− 0.002; 0.087) | 3048 |